Biology subjects

Wittmann, B. J.

Publications and source records attributed to Wittmann, B. J..

6 recordsLinked to original sources

bioRxiv2026

Inverse FoldDir: Structure-conditioned Protein Sequence Design by Dirichlet Flow Matching

Protein engineering has important implications in the bioeconomy, enabling applications in materials, medicine, and energy. A key challenge is designing protein sequences that have a specific form and function. Protein inverse folding seeks to address this challenge by identifying amino acid sequences compatible with a desired protein backbone. This task is central to protein redesign and can provide a sequence design capability for de novo backbones produced by structure-generation methods. Ideally, inverse folding can provide diverse sequence alternatives, fixed residues or motifs, soft biochemical preferences at selected positions, and candidates that remain experimentally useful. We developed Inverse FoldDir, a controllable inverse-folding method that performs iterative denoising on the amino acid probability simplex. Given a backbone structure, the model updates all positions jointly through a learned Dirichlet flow, supporting full sequence generation, fixed-residue inpainting, and user-defined soft residue priors. On the held-out CATH 4.2 test set, Inverse FoldDir achieved a mean TM-score of 84.5 (on a 0-100 scale) and a mean C RMSD of 1.76[A], compared with 83.3 and 1.86[A], respectively, for ESM-IF1, the strongest evaluated baseline on both metrics. Denoising trajectory analyses showed that positions commit at different rates and that some residues change identity late in generation, illustrating whole-sequence refinement rather than one-shot prediction or irreversible sequential decoding. We experimentally tested Inverse FoldDir in an anti-GFP nanobody redesign task, where two of 35 redesigned sequences retained reproducible sfGFP-binding signal across independent assay runs with approximately 43% sequence divergence from the native nanobody. Inverse FoldDir is a structure-conditioned protein redesign method that combines structural recovery, user control, experimental validation, and a natural route toward future property-guided sampling.

bioinformatics↗

bioRxiv2026

The Limits of Sequence-Based Biosecurity Screening Tools in the Age of AI-Assisted Protein Design

Rapid advancements in AI have enabled significant progress in protein and nucleic acid design, but they also pose biosecurity challenges. We examine the vulnerabilities of biosecurity screening software (BSS) to AI-reformulated synthetic homologs of proteins of concern (POCs) that have been fragmented into smaller segments. We evaluate four BSS tools that were recently patched to enhance their AI resiliency. Without any further modification, we found that two of the four tools were capable of robustly detecting fragments as short as 50 nucleotides, demonstrating screening capabilities that exceed those requested in the U.S. Framework for Nucleic Acid Synthesis. Upgraded versions of the other two tools improved performance. Although our findings confirm the effectiveness of the tested BSS tools, at the same time, they emphasize the urgency of developing alternate BSS approaches to counter evolving AI-enabled biosecurity risks.

synthetic biology↗

bioRxiv2025

Experimental Evaluation of AI-Driven Protein Design Risks Using Safe Biological Proxies

Advances in machine learning are providing leaps forward for beneficial applications of protein engineering, while also raising concerns about biosecurity. Recently, Wittmann et al. described an in silico pipeline of generative AI tools to reformulate sequences of concern (SOCs) as synthetic homologs that may evade detection by biosecurity screening software (BSS) used by nucleic acid synthesis providers. Experimental testing of synthetic homologs is required to ascertain the true severity of this vulnerability. We present a generalizable framework to assess biosecurity risk consisting of testing, evaluation, validation, and verification (TEVV) of AI-assisted protein design (AIPD). We determine that common AIPD models in use at the time this study was initiated (early 2024) are not yet powerful enough to reliably rewrite the sequence of a given protein, while both maintaining activity and evading detection by BSS.

synthetic biology↗

bioRxiv2024

Toward AI-Resilient Screening of Nucleic Acid Synthesis Orders: Process, Results, and Recommendations

Fast-moving advances in AI-assisted protein engineering are enabling breakthroughs in the life sciences that promise numerous beneficial applications. At the same time, these new capabilities are creating potential biosecurity challenges by providing new pathways to intentional or accidental synthesis of genes that encode hazardous proteins. The synthesis of nucleic acids is a key choke point in the AI-assisted protein engineering pipeline as it is where digital designs are transformed into physical instructions that can produce potentially harmful proteins. Thus, one focus for efforts to enhance biosecurity in the face of new AI-enabled capabilities is on bolstering the screening of orders by nucleic acid synthesis providers. We describe a multistakeholder, cross-sector effort to address biosecurity challenges with uses of AI-powered biological design tools to reformulate naturally occurring proteins of concern to create synthetic homologs that have low sequence identity to the wild-type proteins. We evaluated the abilities of traditional nucleic acid biosecurity screening tools to detect these synthetic homologs and found that, of tools tested, not all could previously detect such AI-redesigned sequences reliably. However, as we report, patches were built and deployed to improve detection rates over the course of the project, resulting in a final mean detection rate over tools of 97% of the synthetic homologs that were determined, using in-silico metrics, to be more likely to retain wild-type-like function. Finally, we make recommendations on approaches for studying and addressing the rising risk of adversarial AI-assisted protein engineering attacks like the one we identified and worked to mitigate.

synthetic biology↗

bioRxiv2021

evSeq: Cost-Effective Amplicon Sequencing of Every Variant in a Protein Library

Widespread availability of protein sequence-fitness data would revolutionize both our biochemical understanding of proteins and our ability to engineer them. Unfortunately, even though thousands of protein variants are generated and evaluated for fitness during a typical protein engineering campaign, most are never sequenced, leaving a wealth of potential sequence-fitness information untapped. This largely stems from the fact that sequencing is unnecessary for many protein engineering strategies; the added cost and effort of sequencing is thus unjustified. Here, we present every variant sequencing (evSeq), an efficient protocol for sequencing a variable region within every variant gene produced during a protein engineering campaign at a cost of cents per variant. Execution of evSeq is simple, requires no sequencing experience to perform, relies only on resources and services typically available to biology labs, and slots neatly into existing protein engineering workflows. Analysis of evSeq data is likewise made simple by its accompanying software (found at github.com/fhalab/evSeq, documentation at fhalab.github.io/evSeq), which can be run on a personal laptop and was designed to be accessible to users with no computational experience. Low-cost and easy to use, evSeq makes collection of extensive protein variant sequence-fitness data practical.

bioengineering↗

bioRxiv2020

Machine Learning-Assisted Directed Evolution Navigates a Combinatorial Epistatic Fitness Landscape with Minimal Screening Burden

Due to screening limitations, in directed evolution (DE) of proteins it is rarely feasible to fully evaluate combinatorial mutant libraries made by mutagenesis at multiple sites. Instead, DE often involves a single-step greedy optimization in which the mutation in the highest-fitness variant identified in each round of single-site mutagenesis is fixed. However, because the effects of a mutation can depend on the presence or absence of other mutations, the efficiency and effectiveness of a single-step greedy walk is influenced by both the starting variant and the order in which beneficial mutations are identified--the process is path-dependent. We recently demonstrated a path-independent machine learning-assisted approach to directed evolution (MLDE) that allows in silico screening of full combinatorial libraries made by simultaneous saturation mutagenesis, thus explicitly capturing the effects of cooperative mutations and bypassing the path-dependence that can limit greedy optimization. Here, we thoroughly investigate and optimize an MLDE workflow by testing a number of design considerations of the MLDE pipeline. Specifically, we (1) test the effects of different encoding strategies on MLDE efficiency, (2) integrate new models and a training procedure more amenable to protein engineering tasks, and (3) incorporate training set design strategies to avoid information-poor low-fitness protein variants ("holes") in the training data. When applied to an epistatic, hole-filled, four-site combinatorial fitness landscape of protein G domain B1 (GB1), the resulting focused training MLDE (ftMLDE) protocol achieved the global fitness maximum up to 92% of the time at a total screening burden of 470 variants. In contrast, minimal-screening-burden single-step greedy optimization over the GB1 fitness landscape reached the global maximum just 1.2% of the time; ftMLDE matching this minimal screening burden (80 total variants) achieved the global optimum up to 9.6% of the time with a 49% higher expected maximum fitness achieved. To facilitate further development of MLDE, we present the MLDE software package (https://github.com/fhalab/MLDE), which is designed for use by protein engineers without computational or machine learning expertise.

bioinformatics↗